Company Description
Nutex Health Inc. operates as a physician-led, healthcare services, and operations company in the United States.
It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations through its Management Services Organization (MSO) that provides management, administrative, and other support services to its affiliated hospitals and physician groups; and offers a cloud-based platform for healthcare organizations.
The Real Estate segment owns and leases land and hospital buildings. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments that offer 24/7 care.
In addition, the company provides healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; onsite inpatient pharmacies; emergency services; and in-patient services.
The company was founded in 2011 and is headquartered in Houston, Texas.
| Country | United States |
| Founded | 2011 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 800 |
| CEO | Thomas Vo |
Contact Details
Address: 6030 South Rice Avenue, Suite C Houston, Texas 77081 United States | |
| Phone | 713 660 0557 |
| Website | nutexhealth.com |
Stock Details
| Ticker Symbol | NUTX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001479681 |
| CUSIP Number | 67079U306 |
| ISIN Number | US67079U3068 |
| Employer ID | 11-3363609 |
| SIC Code | 7389 |
Key Executives
| Name | Position |
|---|---|
| Dr. Thomas T. Vo M.B.A., M.D. | Chairman of the Board and Chief Executive Officer |
| Dr. Warren Hosseinion M.D. | President and Director |
| Jon C. Bates CPA, M.B.A. | Chief Financial Officer |
| Joshua DeTillio FACHE, M.B.A. | Chief Operating Officer |
| Jennifer Rodriguez | Investor and Public Relations Manager |
| LaTanya Brackens | Director of Compliance |
| Vivian Sanders M.B.A. | Director of Marketing |
| Sarah Wallace | Director of Human Resources |
| Dr. Michael Chang M.D. | Chief Medical Officer |
| Elisa Michael Luqman Esq., J.D., M.B.A. | Chief Legal Officer of SEC |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 16, 2025 | SCHEDULE 13G | Filing |
| Jul 16, 2025 | 8-K | Current Report |
| Jul 11, 2025 | 8-K | Current Report |
| Jun 27, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 27, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 3, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 2, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 2, 2025 | DEF 14A | Other definitive proxy statements |
| May 22, 2025 | PRE 14A | Other preliminary proxy statements |
| May 21, 2025 | 8-K | Current Report |